A Method for Incorporating Ages at Onset in Affected Sibpair Linkage StudiesHsu L.a · Li H.b · Houwing-Duistermaat J.J.c
aDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Wash., and bDepartment of Medicine, University of California, Davis, Calif., USA; cDepartment of Epidemiology and Biostatistics, Erasmus University, Rotterdam, The Netherlands
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Data with varying age at disease onset arise frequently in studies of mapping disease associated genes. Naively combining affected subjects with different ages at onset may result in a much reduced power in detecting the disease genes. In this paper we present a weighted score test statistic to detect the linkage between marker and latent disease loci using affected sibpairs, where the weight is used for assigning differential contribution due to the varying age at onset of each affected sibpair to the test statistic. We show that the weighted test has a correct type I error rate asymptotically. For an illustrative purpose, we analyze a data set from the 12th Genetic Analysis Workshop. The result shows that the weighted tests appear to be able to pinpoint the location of latent disease genes better than the mean IBD test with equal weight with respect to the age at onset. To avoid the potential power loss due to the improper weight, we propose to use a combined test statistic, taking the maximum of two tests, one that is weighted by the age-dependent penetrance function and the other that may be invariant to the age. We conduct an analytical study, comparing the combined test with weighted and equal weight with respect to age test. It shows that the combined test retains the most power of the better one of the two tests being combined.
© 2002 S. Karger AG, Basel
- Abreu PC, Greenberg DA, Hodge SA: Direct power comparisons between simple LOD scores and NPL scores for linkage analysis in complex diseases. Am J Hum Genet 1999;65:847–857.
Billingsley P: Probability and Measure. New York, John Wiley & Sons, 1986.
- Blackwelder WC, Elston RC: A comparison of sib-pair linkage tests for disease susceptibility loci. Genet Epidemiol 1985;2:85–98.
- Bonney GE, Lathrop GM, Lalouel JM: Combined linkage and segregation analysis using regression models. Am J Hum Genet 1988;43:29–37.
- Claus EB, Risch N, Thompson WD: Genetic analysis of breast cancer in cancer and steroid hormone study. Am J Hum Genet 1991;48:232–242.
- Commenges D: Robust genetic linkage analysis based on a score test of homogeneity: The weighted pairwise correlation statistic. Genet Epidemiol 1994;11:189–200.
Cox DR: Regression models and life tables (with Discussion). J Royal Statist Soc B 1972;34:187–220.
- Cui J, Staples MP, Hopper JL, English DR, McCredie MR, Giles GG: Segregation analyses of 1,476 population-based Australian families affected by prostate cancer. Am J Hum Genet 2001;68:1207–1218.
- Dawson DV, Kaplan EB, Elston RC: Extensions to sib-pair linkage tests applicable to disorders characterized by delayed onset. Genet Epidemiol 1990;7:453–466.
- Duggirala R, Blangero J, Almasy L, et al: Linkage of type 2 diabetes mellitus and age at onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet 1999;64:1127–1140.
Fleming TR, Harrington DP: Counting processes and d survival analysis. John Wiley & Sons, New York, 1991.
- Greenberg DA, Abreu PC, Hodge SE: The power to detect linkage in complex disease by means of simple LOD-score analyses. Am J Hum Genet 1998;63:870–9.
- Greenwood CMT, Bull SB: Analysis of affected sib pairs, with covariates – with and without constraints. Am J Hum Genet 1999;64:871–885.
Haines JL, Pericak-Vance MA: Approaches to gene mapping in complex human diseases. John Wiley & Sons, New York, 1998.
- Haseman JK, Elston RC: The investigation of linkage between a quantitative trait and a marker locus. Behav Genet 1972;2:3–19.
- Hodge SE: The information contained in multiple sibling pairs. Genet Epidemiol 1984;1:109–122.
- Hodge SE, Elston RC: Lods, Wrods and Mods: The interpretation of lod scores calculated under different models. Genet Epidemiol 1994;11:329–342.
Kalbfleisch JD, Prentice RL: The statistical analysis of failure time data. Wiley, New York, 1980.
- Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES: Parametric and nonparametric linkage analysis: A unified multipoint approach. Am J Hum Genet 1996;58:1347–1363.
- Lander ES, Schork NJ: Genetic dissection of complex traits. Science 1994;265:2037–2048.
- Li H, Thompson EA: Semiparametric estimation of major gene and random familial effects for age of onset. Biometrics 1997;53:282–293.
- Li H, Hsu L: Effects of ages at onset on the power of affected sibpair and transmission disequilibrium tests. Ann Hum Genet 2000;64:239–254.
- McPeek MS: Optimal allele-sharing statistics for genetic mapping using affected relatives. Genet Epidemiol 1999;16:225–249.
- Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66–71.
- Olson J: Robust estimation of gene frequency and association parameters. Biometrics 1994;50:665–674.
- Olson J: A general conditional-logistic model for affected-relative-pair linkage studies. Am J Hum Genet 1999;65:1760–1769.
Pawlowitzki IH, Edwards JH, Thompson EA: Genetic Mapping of Disease Genes. Academic Press, London, 1997.
- Risch N: Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 1990;46:229–242.
- Scurrah KJ, Palmer LJ, Burton PR: Variance component analysis for pedigree-based censored survival data using weighted linear mixed models (GLMMS) and Gibbs sampling in BUGS. Genet Epidemiol 2000;19:127–148.
- Shirakawa T, Deichmann KA, Izuhara K, Mao Y, Adra CN, Hopkin JM: Atopy and asthma: Genetic variants of IL-4 and IL-13 signalling. Immunol Today 2000;21:60–64.
- Siegmund K, McKnight B: Modeling hazard functions in families. Genet Epidemiol 1998;15:147–171.
- Siegmund KD, Todorov AA: Linkage analysis for diseases with variable age of onset. Hum Hered 1998;50:205–210.
- Suarez BK, Rice J, Reich T: The weighted sib pair IBD distribution: Its use in the detection of linkage. Ann Hum Genet 1978;42:87–94.
- Weeks DE, Lang K: The affected-pedigree-member method of linkage analysis. Am J Hum Genet 1988;42:315–326.
- Whittemore AS: Genome scanning for linkage: An overview. Am J Hum Genet 1996;59:704–716.
Wijsman EM, Almasy L, Amos CI, Borecki T, Falk CT, King TM, Martinez MM, Meyers D, Neuman R, Olson, JM, Rich S, Spence MA, Thomas DC, Vieland VJ, Witte JS, MacCluer JW: Analysis of complex genetic traits: Applications to asthma and simulated data. Genet Epidemiol 2001;21(suppl 1):S1–S853.
Yang S, Hsu L, Zhao LP: Combining two asymptotically normal tests. Submitted, 2002.
- Zhao LP, Quiaoit F, Hsu L, Aragaki C: An efficient, robust and unified framework for mapping complex traits (I): Two-point analysis. Am J Med Genet 1998;77:366–383.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.